This week’s article looked at the relationship between sickness
behavior and the gut biome and more specifically the influence of probiotics. I
found the article as a whole quite interesting, as the gut-brain connection is
largely novel to me, the introduction two weeks ago was my first time learning
about it. I found it interesting that the introduction focused more on the previous
studies/knowledge on which several of the paper’s claims were based, instead of
talking about the relevance and implications of the research. ‘
As with previous studies, it is noteworthy that this one
used only male mice. And also, as with previous studies, I would question how
well social exploratory behavior is indicative of sickness behavior specifically.
The article states that it is a “highly reproducible and robust behavioral
paradigm,” however the paradigm was also used to measure depression, so that
raises some questions. I am a little confused as to why gut permeability was
measured, and because there was no significant difference between the mice it
was not really further discussed.
Within the results for the sickness behavior it was
interesting that both the time spent in social investigation and time spend
being immobile were included. While the difference in social investigation
between BDL placebo mica and BDL VS3 mice was statistically significant it
appears that the difference is much smaller than comparing the sham surgery to
the BDL surgery in general. The difference in time spent immobile seems to be
much larger. I do wonder how different the sham surgery is from the BDL surgery
and where these behavioral differences are due to inflammation induced sickness
behavior or due to other surgical complications.
The most confusing result for me was the composition of the
gut microbiota between the surgery groups and between the VSL#3 treatment
groups was not different. While the changes in behavior and effects on systemic
immunity seem to be clearly linked to the surgery or to the VSL#3 treatment, I
would have thought this would be reflected in a different microbiome composition.
On the other hand, the clearest and seemingly relevant result is the difference
in TNF-alpha levels between BDL placebo and BDL VSL#3 mice. This was then
linked to the novel pathway that the increased microglial activation is
followed by monocyte recruitment int the brain which leads to the development
of sickness behaviors.
The discussion cited a study about long term hippocampal
potentiation in a diabetes model due to probiotic, which is very interesting to
me. I think I will write my grant proposal about something diabetes related so
I will check out that article.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.